Bill Haney believes there’s a better way to build a biotech — and now he has $100M more at Skyhawk to prove it
Bill Haney wanted to do things differently when he launched Skyhawk Therapeutics at the beginning of the year with $8 million in seed cash from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
